• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>AstraZeneca PLC ADR

AstraZeneca PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. AstraZeneca , MD Anderson Enter Collaboration to Help Improve Patient Outcomes in Ovarian/ Gynecologic Cancers

    AstraZeneca , MD Anderson Enter Collaboration to Help Improve Patient Outcomes in Ovarian/ Gynecologic Cancers

  2. Hutchison China Meditech to Distribute AstraZeneca's Seroquel in China

    Hutchison China Meditech to Distribute AstraZeneca's Seroquel in China

  3. Teva's generic version of AstraZeneca's Nexium gets FDA approval

    Teva's generic version of AstraZeneca's Nexium gets FDA approval

  4. AstraZeneca's Lesinurad Gout Treatment Receives EMA Approval

    AstraZeneca's Lesinurad Gout Treatment Receives EMA Approval

  5. AstraZeneca's Brilinta Study Meets Primary Targets

    AstraZeneca's Brilinta Study Meets Primary Targets

  6. Correction to AstraZeneca's Lesinurad Gout Story

    Correction to AstraZeneca's Lesinurad Gout Story

  7. Pfizer Hit by Stronger Dollar, Patent Losses, Lawsuit Settlement -- 3rd Update

    Pfizer Hit by Stronger Dollar, Patent Losses, Lawsuit Settlement -- 3rd Update

  8. Pfizer May Go Shopping for Growth

    Despite an improving pipeline and slowing patent losses, a lackluster growth outlook will likely drive Pfizer to acquire assets in the near term.

  9. TransCelerate BioPharma Welcomes Merck & Co. and Novo Nordisk to its Membership Roster

    TransCelerate BioPharma Welcomes Merck & Co. and Novo Nordisk to its Membership Roster

  10. Pfizer Hit by Stronger Dollar, Patent Losses -- Update

    Pfizer Hit by Stronger Dollar, Patent Losses -- Update

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.